Events

Bioluz S.A. enter co-development relationship for I.V. pharmaceuticals

Bioluz S.A., Contract Manufacturing Organization, has signed a co-development contract with Actavis, one of the leading generic pharmaceutical manufacturers in the world.

There is a growing trend for the ready to use molecules, Bioluz' strategy is to respond to this increasing demand on the international market with the implementation of the

aseptic filling line.

Bioluz is a fully integrated drug manufacturer focused on premixed drugs in flexible bags with over 25 years of experience, and is the only European CMO to offer aseptic filling of I.V. drugs in sterile flexible bags. Additional information is available at the Company's website at www.bioluz.com

Actavis' hospital division has been rapidly expanding its presence in the hospitals market and has a range of injectable products in addition to a comprehensive oncology range comprising over 30 molecules. Additional information is available at the Company's website at www.actavis.com

Jean Jacques Chappaz, Bioluz CEO commented: "The deal signed with Actavis is in line our will to partner with the major pharmaceutical companies. There is no doubt about increasing demand on premixed I.V. drugs, mainly for safety issues; our new filling line enables to extend the number of molecules offered as ready-to-use".

James Burt, Global Director of Actavis' Hospital Unit commented: "The contract with Bioluz signifies an important development for our hospitals business, as it enables us to provide further diversity in our product offering and a strong foothold in the fast growing

market for I.V. drugs in ready to use format".